Treatment with rGal-1 in mice with IgE-mediated allergic conjunctivitis or OVA-induced atopic dermatitis resulted in resolution of clinical signs and reduced levels of Th2 cytokines and chemokines [11, 13]. The gene discussed is IGHE; the disease is atopic conjunctivitis.